Business Wire · MANE · October 18, 2026

Veradermics to Hold Conference Call to Discuss Topline Results from Phase 3 ‘304' Clinical Trial of VDPHL01 in Males with Mild-to-Moderate Pattern Hair Loss

Get the app for more

Explore stock news, insights and company research.